Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $90 to $100.
Jim Cramer Warns More ‘Pain’ Ahead For Nvidia As Stock Rips On Morgan Stanley Earnings Prediction
NVIDIA Corp (NASDAQ: NVDA) shares are ripping higher Monday after Morgan Stanley told clients to step in and buy the stock ahead of earnings.